Govinda Bhisetti | Principal Investigator

Govinda Bhisetti, Principal Investigator, Biogen

Govinda Bhisetti is a Principal Investigator and Head of Computational Chemistry department at Biogen. Prior to Biogen, Govinda worked in the Computational Sciences department at Vertex Pharmaceuticals Inc. for 22 years where he led molecular modeling and drug design efforts on several drug discovery projects.
He is a co-inventor of two approved AIDS drugs, Agenerase and Lexiva, and one Hepatitis C drug, Incivek. He contributed to the discovery of several second-generation protease inhibitors for HIV and Hepatitis C. Govinda is a named inventor on 25 US patents. He authored/co-authored 70 research papers (including review articles and book chapters).
Govinda got his Ph. D. from Indian Institute of Science, Bangalore, and was a post-doctoral fellow at Scripps Research Institute, La Jolla, CA. His current activities include application of state of the art computational methods in the discovery of novel drugs for neurodegenerative and neuroinflammatory diseases.


BioData West: Day 2 @ 14:10

Understanding the power of Quantum Computing in Drug Discovery

  • By leveraging the properties of quantum physics in computing, quantum computers are being designed to be millions of times faster than classical computing for solving complex business problems
  • Quantum computing has the potential to transform traditional R&D drug discovery processes, improve speed and productivity alongside significantly reducing costs and accelerating access to new therapies for patients
  • Unveiling a first-of-its-kind quantum-enabled molecular comparison application that could significantly improve advanced molecular design to speed up drug discovery for complex neurological conditions

BioData West: Day 2 @ 14:40


back to speakers